PDB-code
Browse kinase entries (page 75 of 282)
First 71 72 73 PreviousLast79 78 77 Next| # | Kinase | Family | Group | PDB | Chain | (Alternate) Model | Orthosteric ligand | Organism | Details | File |
|---|---|---|---|---|---|---|---|---|---|---|
 | CSNK2A1 (CK2a1) | CK2 | CMGC | 3q9w | A | A | 3-methyl-1,6,8-trihydroxyanthraquinone | Human | Show |  |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3q9w | A | B | 3-methyl-1,6,8-trihydroxyanthraquinone | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3q9x | A | A | 3-methyl-1,6,8-trihydroxyanthraquinone | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3q9x | A | B | 3-methyl-1,6,8-trihydroxyanthraquinone | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3q9x | B | A | 3-methyl-1,6,8-trihydroxyanthraquinone | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3q9x | B | B | 3-methyl-1,6,8-trihydroxyanthraquinone | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3q9y | A | A | 1,2,5,8-tetrahydroxyanthracene-9,10-dione | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3q9y | A | B | 1,2,5,8-tetrahydroxyanthracene-9,10-dione | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3q9z | A | A | 1,2,5,8-tetrahydroxyanthracene-9,10-dione | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3q9z | A | B | 1,2,5,8-tetrahydroxyanthracene-9,10-dione | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3q9z | B | A | 1,2,5,8-tetrahydroxyanthracene-9,10-dione | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3q9z | B | B | 1,2,5,8-tetrahydroxyanthracene-9,10-dione | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3qa0 | A | A | - | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3qa0 | A | B | - | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3qa0 | B | A | - | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3qa0 | B | B | - | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3r0t | A | A | 3-(cyclopropylamino)-5-{[3-(trifluoromethyl)phenyl]amino}pyrimido[4,5-c]quinoline-8-carboxylic acid | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3r0t | A | B | 3-(cyclopropylamino)-5-{[3-(trifluoromethyl)phenyl]amino}pyrimido[4,5-c]quinoline-8-carboxylic acid | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3rps | A | 3-(4,5,6,7-tetrabromo-1h-benzotriazol-1-yl)propan-1-ol | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3rps | B | - | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3u4u | A | 3-{5-(acetylamino)-3-[3-cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]-1h-indol-1-yl}propanoic acid | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3u87 | A | phosphoaminophosphonic acid-adenylate ester | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3u87 | B | phosphoaminophosphonic acid-adenylate ester | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3u9c | A | 7-hydroxy-3h-phenoxazin-3-one | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3u9c | B | 7-hydroxy-3h-phenoxazin-3-one | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3w8l | A | - | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3w8l | B | - | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3war | A | A | nicotinic acid | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3war | A | B | nicotinic acid | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3wik | A | n-[5-(4-nitrophenyl)-1,3,4-thiadiazol-2-yl]acetamide | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3wil | A | {[(2z)-2-(3,4-dimethoxybenzylidene)-3-oxo-2,3-dihydro-1-benzofuran-6-yl]oxy}acetic acid | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3wow | A | phosphoaminophosphonic acid-adenylate ester | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 4dgl | C | - | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 4dgl | D | - | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 4fbx | A | - | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 4grb | A | 5-(2-{[4-(dimethylcarbamoyl)phenyl]amino}-4-methoxypyrimidin-5-yl)thiophene-3-carboxylic acid | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 4gub | A | n-[5-({3-cyano-7-[(1-methyl-1h-imidazol-4-yl)amino]pyrazolo[1,5-a]pyrimidin-5-yl}amino)-2-methylphenyl]acetamide | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 4ib5 | A | A | - | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 4ib5 | A | B | - | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 4ib5 | B | A | - | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 4ib5 | B | B | - | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 4ib5 | C | A | - | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 4ib5 | C | B | - | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 4kwp | A | A | 4,5,6,7-tetrabromo-1-(2-deoxy-beta-d-erythro-pentofuranosyl)-1h-benzimidazole | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 4kwp | A | B | 4,5,6,7-tetrabromo-1-(2-deoxy-beta-d-erythro-pentofuranosyl)-1h-benzimidazole | Human | Show | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 4md7 | E | - | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 4md7 | F | - | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 4md7 | G | - | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 4md7 | H | - | Human | Show | | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 4md8 | E | - | Human | Show | |
